BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 21028850)

  • 1. The assembly-inducing laulimalide/peloruside a binding site on tubulin: molecular modeling and biochemical studies with [³H]peloruside A.
    Nguyen TL; Xu X; Gussio R; Ghosh AK; Hamel E
    J Chem Inf Model; 2010 Nov; 50(11):2019-28. PubMed ID: 21028850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis of microtubule stabilization by laulimalide and peloruside A.
    Prota AE; Bargsten K; Northcote PT; Marsh M; Altmann KH; Miller JH; Díaz JF; Steinmetz MO
    Angew Chem Int Ed Engl; 2014 Feb; 53(6):1621-5. PubMed ID: 24470331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peloruside- and laulimalide-resistant human ovarian carcinoma cells have βI-tubulin mutations and altered expression of βII- and βIII-tubulin isotypes.
    Kanakkanthara A; Wilmes A; O'Brate A; Escuin D; Chan A; Gjyrezi A; Crawford J; Rawson P; Kivell B; Northcote PT; Hamel E; Giannakakou P; Miller JH
    Mol Cancer Ther; 2011 Aug; 10(8):1419-29. PubMed ID: 21653684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects of peloruside A and laulimalide with taxoid site drugs, but not with each other, on tubulin assembly.
    Hamel E; Day BW; Miller JH; Jung MK; Northcote PT; Ghosh AK; Curran DP; Cushman M; Nicolaou KC; Paterson I; Sorensen EJ
    Mol Pharmacol; 2006 Nov; 70(5):1555-64. PubMed ID: 16887932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. βI-tubulin mutations in the laulimalide/peloruside binding site mediate drug sensitivity by altering drug-tubulin interactions and microtubule stability.
    Kanakkanthara A; Rowe MR; Field JJ; Northcote PT; Teesdale-Spittle PH; Miller JH
    Cancer Lett; 2015 Sep; 365(2):251-60. PubMed ID: 26052091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peloruside A does not bind to the taxoid site on beta-tubulin and retains its activity in multidrug-resistant cell lines.
    Gaitanos TN; Buey RM; Díaz JF; Northcote PT; Teesdale-Spittle P; Andreu JM; Miller JH
    Cancer Res; 2004 Aug; 64(15):5063-7. PubMed ID: 15289305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Computational comparison of microtubule-stabilising agents laulimalide and peloruside with taxol and colchicine.
    Pineda O; Farràs J; Maccari L; Manetti F; Botta M; Vilarrasa J
    Bioorg Med Chem Lett; 2004 Oct; 14(19):4825-9. PubMed ID: 15341932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peloruside, laulimalide, and noscapine interactions with beta-tubulin.
    Gajewski MM; Alisaraie L; Tuszynski JA
    Pharm Res; 2012 Nov; 29(11):2985-93. PubMed ID: 22733149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular recognition of peloruside A by microtubules. The C24 primary alcohol is essential for biological activity.
    Pera B; Razzak M; Trigili C; Pineda O; Canales A; Buey RM; Jiménez-Barbero J; Northcote PT; Paterson I; Barasoain I; Díaz JF
    Chembiochem; 2010 Aug; 11(12):1669-78. PubMed ID: 20665616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laulimalide and peloruside A inhibit mitosis of Saccharomyces cerevisiae by preventing microtubule depolymerisation-dependent steps in chromosome separation and nuclear positioning.
    Best HA; Matthews JH; Heathcott RW; Hanna R; Leahy DC; Coorey NV; Bellows DS; Atkinson PH; Miller JH
    Mol Biosyst; 2013 Nov; 9(11):2842-52. PubMed ID: 24056987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hallmarks of molecular action of microtubule stabilizing agents: effects of epothilone B, ixabepilone, peloruside A, and laulimalide on microtubule conformation.
    Khrapunovich-Baine M; Menon V; Yang CP; Northcote PT; Miller JH; Angeletti RH; Fiser A; Horwitz SB; Xiao H
    J Biol Chem; 2011 Apr; 286(13):11765-78. PubMed ID: 21245138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. βII-tubulin and βIII-tubulin mediate sensitivity to peloruside A and laulimalide, but not paclitaxel or vinblastine, in human ovarian carcinoma cells.
    Kanakkanthara A; Northcote PT; Miller JH
    Mol Cancer Ther; 2012 Feb; 11(2):393-404. PubMed ID: 22180309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of lateral and longitudinal interdimeric interactions in microtubule models by Laulimalide and Peloruside A association: A molecular modeling approach on the mechanism of microtubule stabilizing agents.
    Zúñiga MA; Alderete JB; Jaña GA; Fernandez PA; Ramos MJ; Jiménez VA
    Chem Biol Drug Des; 2018 May; 91(5):1042-1055. PubMed ID: 29316292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A unique mode of microtubule stabilization induced by peloruside A.
    Huzil JT; Chik JK; Slysz GW; Freedman H; Tuszynski J; Taylor RE; Sackett DL; Schriemer DC
    J Mol Biol; 2008 May; 378(5):1016-30. PubMed ID: 18405918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic interactions between peloruside A and other microtubule-stabilizing and destabilizing agents in cultured human ovarian carcinoma cells and murine T cells.
    Wilmes A; O'Sullivan D; Chan A; Chandrahasen C; Paterson I; Northcote PT; La Flamme AC; Miller JH
    Cancer Chemother Pharmacol; 2011 Jul; 68(1):117-26. PubMed ID: 20848285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterizing the laulimalide-peloruside binding site using site-directed mutagenesis of TUB2 in S. cerevisiae.
    Hanna R; Maass DR; Atkinson PH; Northcote PT; Teesdale-Spittle PH; Bellows DS; Miller JH
    Mol Biosyst; 2014 Jan; 10(1):110-6. PubMed ID: 24161989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural insight into the role of Gln293Met mutation on the Peloruside A/Laulimalide association with αβ-tubulin from molecular dynamics simulations, binding free energy calculations and weak interactions analysis.
    Zúñiga MA; Alderete JB; Jaña GA; Jiménez VA
    J Comput Aided Mol Des; 2017 Jul; 31(7):643-652. PubMed ID: 28597356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resistance to peloruside A and laulimalide: functional significance of acquired βI-tubulin mutations at sites important for drug-tubulin binding.
    Kanakkanthara A; Eras J; Northcote PT; Cabral F; Miller JH
    Curr Cancer Drug Targets; 2014; 14(1):79-90. PubMed ID: 24245693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peloruside A, a novel antimitotic agent with paclitaxel-like microtubule- stabilizing activity.
    Hood KA; West LM; Rouwé B; Northcote PT; Berridge MV; Wakefield SJ; Miller JH
    Cancer Res; 2002 Jun; 62(12):3356-60. PubMed ID: 12067973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docking and molecular dynamics studies of the binding between Peloruside A and tubulin.
    Liao SY; Mo GQ; Chen JC; Zheng KC
    J Enzyme Inhib Med Chem; 2014 Oct; 29(5):702-9. PubMed ID: 24156744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.